Johnson & Johnson posts lower profit
July 14, 2009 at 08:41 AM EDT
Johnson & Johnson reports moderately lower second-quarter earnings, due largely to increased generic competition for two of its top-selling prescription drugs and decreased demand for its consumer products.
